Holdings of T. Rowe Price Health Sciences Fund, Inc.
T. ROWE PRICE HEALTH SCIENCES FUND, INC. · Original filing · Compare with another fund · Report an error
- Net assets
- 11.9B $ including 11.3B $ in equities, 94.7 %
- Positions
- 168 in 16 countries
- Bond lines
- 1 from 1 company
- Top ten
- 47.6 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 1,422,387 | 1.7B $ | 14.28 % |
| 2 | Johnson & Johnson | 3,118,531 | 792M $ | 6.63 % |
| 3 | UnitedHealth Group Inc | 1,721,743 | 715.6M $ | 5.99 % |
| 4 | AbbVie Inc | 2,421,312 | 609.3M $ | 5.10 % |
| 5 | Merck & Co Inc | 3,725,492 | 478.7M $ | 4.01 % |
| 6 | Gilead Sciences Inc | 2,667,336 | 337M $ | 2.82 % |
| 7 | Thermo Fisher Scientific Inc | 600,779 | 301.2M $ | 2.52 % |
| 8 | Vertex Pharmaceuticals Inc | 548,135 | 272.3M $ | 2.28 % |
| 9 | Bristol-Myers Squibb Co | 4,370,872 | 251.8M $ | 2.11 % |
| 10 | Abbott Laboratories | 2,483,400 | 225.3M $ | 1.89 % |
| 11 | Intuitive Surgical Inc | 562,584 | 223.7M $ | 1.87 % |
| 12 | Amgen Inc | 600,204 | 217.3M $ | 1.82 % |
| 13 | Stryker Corp | 676,162 | 212.9M $ | 1.78 % |
| 14 | Elevance Health Inc | 472,238 | 182.6M $ | 1.53 % |
| 15 | NATERA INC | 632,146 | 171.6M $ | 1.44 % |
| 16 | Danaher Corp | 893,771 | 170.2M $ | 1.43 % |
| 17 | GUARDANT HEALTH INC | 975,588 | 146.4M $ | 1.23 % |
| 18 | Cardinal Health Inc | 519,232 | 123.3M $ | 1.03 % |
| 19 | ROYALTY PHARMA PLC | 2,061,943 | 115.6M $ | 0.97 % |
| 20 | CVS Health Corp | 1,082,139 | 111.9M $ | 0.94 % |
| 21 | TENET HEALTHCARE CORP | 598,302 | 111.9M $ | 0.94 % |
| 22 | KYMERA THERAPEUTICS INC | 924,967 | 106.1M $ | 0.89 % |
| 23 | Protagonist Therapeutics Inc | 828,559 | 101.6M $ | 0.85 % |
| 24 | MODERNA INC | 1,412,800 | 98.9M $ | 0.83 % |
| 25 | BRIGHTSPRING HEALTH SERVICES INC | 1,409,277 | 98.3M $ | 0.82 % |
| 26 | REVOLUTION MEDICINES INC | 495,491 | 92.8M $ | 0.78 % |
| 27 | Roivant Sciences Ltd | 2,372,373 | 84M $ | 0.70 % |
| 28 | ALNYLAM PHARMACEUTICALS INC | 266,374 | 80.2M $ | 0.67 % |
| 29 | VIATRIS INC | 4,947,140 | 78.6M $ | 0.66 % |
| 30 | Charles River Laboratories International Inc | 326,233 | 74M $ | 0.62 % |
| 31 | Argenx SE | 76,622 | 71.1M $ | 0.60 % |
| 32 | Edwards Lifesciences Corp | 780,377 | 70.6M $ | 0.59 % |
| 33 | Centene Corp | 1,058,031 | 67.9M $ | 0.57 % |
| 34 | Spyre Therapeutics Inc | 711,845 | 63.2M $ | 0.53 % |
| 35 | Definium Therapeutics Inc | 1,287,318 | 60.6M $ | 0.51 % |
| 36 | Insmed Inc | 548,295 | 58.5M $ | 0.49 % |
| 37 | TWIST BIOSCIENCE CORP | 555,000 | 57.1M $ | 0.48 % |
| 38 | Chugai Pharmaceutical Co Ltd | 1,171,600 | 54.1M $ | 0.45 % |
| 39 | AstraZeneca PLC | 279,235 | 52.9M $ | 0.44 % |
| 40 | United Therapeutics Corp | 96,653 | 52.4M $ | 0.44 % |
| 41 | Krystal Biotech Inc | 138,857 | 51.6M $ | 0.43 % |
| 42 | Boston Scientific Corp | 1,196,671 | 51.1M $ | 0.43 % |
| 43 | Medtronic PLC | 630,200 | 49.3M $ | 0.41 % |
| 44 | Erasca Inc | 2,584,513 | 47.3M $ | 0.40 % |
| 45 | Billiontoone Inc | 377,575 | 45.3M $ | 0.38 % |
| 46 | Praxis Precision Medicines Inc | 133,320 | 44.6M $ | 0.37 % |
| 47 | Medpace Holdings Inc | 84,145 | 44.6M $ | 0.37 % |
| 48 | Monte Rosa Therapeutics Inc | 1,823,210 | 44.1M $ | 0.37 % |
| 49 | Tango Therapeutics Inc | 1,401,293 | 43.8M $ | 0.37 % |
| 50 | ORUKA THERAPEUTICS INC | 451,118 | 42.9M $ | 0.36 % |
| 51 | Ascendis Pharma A/S | 159,873 | 42.6M $ | 0.36 % |
| 52 | BeOne Medicines Ltd | 1,942,196 | 42.3M $ | 0.35 % |
| 53 | Humana Inc | 106,300 | 42.2M $ | 0.35 % |
| 54 | Dianthus Therapeutics Inc | 428,750 | 41.8M $ | 0.35 % |
| 55 | Scholar Rock Holding Corp | 738,180 | 40.6M $ | 0.34 % |
| 56 | Kodiak Sciences Inc | 1,013,711 | 39.5M $ | 0.33 % |
| 57 | Axsome Therapeutics Inc | 151,210 | 37M $ | 0.31 % |
| 58 | Summit Therapeutics Inc | 2,531,231 | 36.9M $ | 0.31 % |
| 59 | Novo Nordisk A/S | 752,169 | 36.1M $ | 0.30 % |
| 60 | Regeneron Pharmaceuticals Inc | 55,661 | 34.7M $ | 0.29 % |
| 61 | Relay Therapeutics Inc | 1,840,896 | 34.4M $ | 0.29 % |
| 62 | IONIS PHARMACEUTICALS INC | 433,923 | 34.4M $ | 0.29 % |
| 63 | CYTOKINETICS INC | 395,436 | 33.7M $ | 0.28 % |
| 64 | VERA THERAPEUTICS INC | 784,306 | 33.7M $ | 0.28 % |
| 65 | Enliven Therapeutics Inc | 647,454 | 32.9M $ | 0.28 % |
| 66 | Agilent Technologies Inc | 244,800 | 32.5M $ | 0.27 % |
| 67 | MBX BIOSCIENCES INC | 586,309 | 32.4M $ | 0.27 % |
| 68 | CG ONCOLOGY INC | 437,973 | 31.1M $ | 0.26 % |
| 69 | NEWAMSTERDAM PHARMA COMPANY NV | 912,500 | 30.9M $ | 0.26 % |
| 70 | Waters Corp | 81,880 | 30.7M $ | 0.26 % |
| 71 | Crinetics Pharmaceuticals Inc | 813,056 | 30.4M $ | 0.25 % |
| 72 | Madrigal Pharmaceuticals Inc | 56,364 | 30.3M $ | 0.25 % |
| 73 | Liquidia Corp | 364,952 | 29.1M $ | 0.24 % |
| 74 | MIRUM PHARMACEUTICALS INC | 247,530 | 29M $ | 0.24 % |
| 75 | Beam Therapeutics Inc | 842,092 | 28.9M $ | 0.24 % |
| 76 | Nurix Therapeutics Inc | 1,186,512 | 28.8M $ | 0.24 % |
| 77 | West Pharmaceutical Services Inc | 77,225 | 27.7M $ | 0.23 % |
| 78 | Ideaya Biosciences Inc | 726,971 | 27.1M $ | 0.23 % |
| 79 | Bridgebio Pharma Inc | 363,249 | 27.1M $ | 0.23 % |
| 80 | Teva Pharmaceutical Industries Ltd | 794,500 | 26.9M $ | 0.23 % |
| 81 | Rhythm Pharmaceuticals Inc | 241,658 | 26.8M $ | 0.22 % |
| 82 | VIRIDIAN THERAPEUTICS INC | 1,447,742 | 26.6M $ | 0.22 % |
| 83 | Alkermes PLC | 503,800 | 26.4M $ | 0.22 % |
| 84 | ALIGNMENT HEALTHCARE INC | 1,065,985 | 25.4M $ | 0.21 % |
| 85 | VAXCYTE INC | 425,845 | 24.8M $ | 0.21 % |
| 86 | Rapport Therapeutics Inc | 571,905 | 23.8M $ | 0.20 % |
| 87 | Immunome Inc | 1,092,814 | 23.2M $ | 0.19 % |
| 88 | STRUCTURE THERAPEUTICS INC | 419,407 | 22.5M $ | 0.19 % |
| 89 | PALVELLA THERAPEUTICS INC | 144,220 | 22M $ | 0.18 % |
| 90 | Climb Bio Inc | 1,635,973 | 21.3M $ | 0.18 % |
| 91 | ICON PLC | 120,200 | 20.9M $ | 0.17 % |
| 92 | Immunocore Holdings PLC | 645,268 | 20.5M $ | 0.17 % |
| 93 | Kailera Therapeutics Inc | 904,283 | 19.9M $ | 0.17 % |
| 94 | Celldex Therapeutics Inc | 494,692 | 18.4M $ | 0.15 % |
| 95 | Bicara Therapeutics Inc | 591,014 | 17.5M $ | 0.15 % |
| 96 | Cencora Inc | 61,157 | 17.3M $ | 0.14 % |
| 97 | Sonova Holding AG | 72,348 | 17.2M $ | 0.14 % |
| 98 | ALUMIS INC | 594,923 | 16.7M $ | 0.14 % |
| 99 | Apogee Therapeutics Inc | 126,098 | 16.7M $ | 0.14 % |
| 100 | ORIC Pharmaceuticals Inc | 1,533,122 | 16.6M $ | 0.14 % |
The bonds it holds
This fund holds one bond line from 1 company. Only companies that already have a page on Titelia appear here.
| Rank | Company | Bond lines | Value | Weight |
|---|---|---|---|---|
| 1 | Immunocore Holdings PLC | 1 | 12.9M $ | 0.11 % |
Sector breakdown
- Health care 72.2 %
- Technology 0.1 %
- Unattributed 27.6 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 98.9 %
- JPY 0.5 %
- HKD 0.4 %
- CHF 0.2 %
- EUR 0.1 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 94.6 %
- Netherlands 1.0 %
- Bermuda 0.7 %
- Denmark 0.7 %
- United Kingdom 0.5 %
- Japan 0.5 %
- Ireland 0.4 %
- Hong Kong SAR China 0.4 %
- Cayman Islands 0.2 %
- Israel 0.2 %
- France 0.2 %
- Switzerland 0.2 %
- Other countries 0.3 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 144 | 10.7B $ | 94.60 % |
| 2 | Netherlands | 4 | 115M $ | 1.02 % |
| 3 | Bermuda | 1 | 84M $ | 0.74 % |
| 4 | Denmark | 2 | 78.7M $ | 0.70 % |
| 5 | United Kingdom | 2 | 55.6M $ | 0.49 % |
| 6 | Japan | 1 | 54.1M $ | 0.48 % |
| 7 | Ireland | 2 | 47.3M $ | 0.42 % |
| 8 | Hong Kong SAR China | 1 | 42.3M $ | 0.37 % |
| 9 | Cayman Islands | 2 | 27.8M $ | 0.25 % |
| 10 | Israel | 1 | 26.9M $ | 0.24 % |
| 11 | France | 3 | 26M $ | 0.23 % |
| 12 | Switzerland | 1 | 17.2M $ | 0.15 % |
Cite this page
Titelia. "Holdings of T. Rowe Price Health Sciences Fund, Inc.". https://titelia.com/en/funds/S000002088